2016). Ion channel mechanisms of rat tail artery contraction-relaxation by menthol involving, respectively, TRPM8 activation and L-type Ca2+ channel inhibition. American Journal of Physiology -Heart and Circulatory Physiology. Summary Transient receptor potential melastatin 8 (TRPM8) is the principal cold and menthol receptor channel. Characterized primarily for its cold sensing role in sensory neurons, it is expressed and functional in several non-neuronal tissues, including vasculature. We previously demonstrated that menthol causes variable mechanical responses (vasoconstriction, vasodilatation or biphasic reactions) in isolated arteries, depending on vascular tone. Here we aimed to dissect the specific ion channel mechanisms and corresponding Ca 2+ signalling pathways underlying such complex responses to menthol and other TRPM8 ligands in rat tail artery myocytes using patch-clamp electrophysiology, confocal Ca 2+ imaging and ratiometric Ca 2+ recording. Menthol (300 μM, a concentration typically used to induce TRPM8 currents) strongly inhibited L-type Ca 2+ channel current (L-ICa) in isolated myocytes, especially it's sustained component, most relevant for depolarisation-induced vasoconstriction. In contraction studies, with nifedipine present (10 μM) to abolish L-ICa contribution to phenylephrine (PE)-induced vasoconstrictions of vascular rings, a marked increase in tone was observed with menthol, similarly to resting (i.e. without α-adrenoceptor stimulation by PE) conditions, when L-type channels were mostly deactivated. Menthol-induced increases in PE-induced vasoconstrictions could it be inhibited both by the TRPM8 antagonist AMTB (thus confirming specific role of TRPM8), and by cyclopiazonic acid treatment to deplete Ca 2+ stores, pointing to a major contribution of Ca 2+ -release from the sarcoplasmic reticulum in these contractile responses. Immunocytochemical analysis has indeed revealed colocalisation of TRPM8 and InsP3 receptors . Moreover, menthol Ca 2+ responses, which were somewhat reduced under Ca 2+ -free conditions, were strongly reduced by cyclopiazonic acid treatment to deplete Ca 2+ store, while caffeine-induced Ca 2+ responses were blunted in the presence of menthol. Finally, two other common TRPM8 agonists, WS-12 and icilin, also inhibited L-ICa. With respect to L-ICa inhibition, WS-12 is the most selective agonist. It augmented PE-induced contractions, while any secondary phase of vasorelaxation (as with menthol) was completely lacking. Thus, TRPM8 channels are functionally active in rat tail artery myocytes and play a distinct direct stimulatory role in control of vascular tone.
Introduction
Transient receptor potential melastatin member 8 (TRPM8) is an cation channel best known for its role in sensory nerve endings where it is activated by cold temperatures and cooling compounds, such as menthol and icilin (23, 25, 27) . In nerve terminals, TRPM8 channel opening initiates membrane depolarization accompanied by an acceleration of action potential discharge that ultimately result in the perception of environmental cold (3, 23) . Although the role of TRPM8 is now well established as the primary sensor of thermal stimuli in the innocuous cold range (3, 12, 13) , with a temperature threshold of ~26°C (25) , the channel was first cloned and identified in prostate epithelia and several types of carcinoma (38) , tissues in which temperature would not be expected to deviate substantially from that of the core body temperature. TRPM8 expression has now been found in several non-neuronal tissues including the bladder and male genital tract (34) , lung epithelia (32) , and in the vasculature (16, 17, 26, 35, 42, 43) . Additionally, numerous endogenous molecules have been proposed to increase (phosphatidylinositol 4,5-biphosphate and lysophospholipids; 1, 2, 20, 30) and decrease (arachidonic acid; 2, 5) TRPM8 activity and enzymes protein kinase A and protein kinase C have been proposed to regulate TRPM8 by altering its phosphorylated state (4, 5, 30) , thus providing putative endogenous biochemical modulatory pathways for TRPM8, distinct from thermal stimuli. These findings raise important questions as to the whole spectrum of expression and functions of this truly polymodal protein that forms Ca 2+ -permeable cation channels.
There is strong evidence to indicate TRPM8 gene expression in rat and mouse vascular smooth muscle (VSM; 17, 35, 42, 43) . As a Ca 2+ -permeable cation channel (PCa/PNa~1-3; 25, 27) , activation of TRPM8 located on the plasma membrane and/or the membrane of the sarcoplasmic reticulum (SR) of these VSM cells (VSMC) would be expected to induce increased intracellular Ca 2+ ([Ca 2+ ]i). In a study by Yang et al. (43) , the application of menthol (300 μM) to transiently cultured rat aortic and pulmonary VSMCs resulted in the expected robust increases in [Ca 2+ ]i that were dependent on the presence of extracellular Ca 2+ and could be blocked by the non-selective cation channel inhibitor Ni 2+ (300 μM), while the L-type voltagegated Ca 2+ channel (L-VGCC) blocker nifedipine (1 μM) had no effect (43). These findings indicated that menthol-induced responses in rat aortic and pulmonary VSMCs were entirely mediated by Ca 2+ influx, suggesting TRPM8 expression on the plasma membrane of these cells.
In our earlier work we used an organ bath tensiometric preparation along with TRPM8 pharmacological modulators, menthol and icilin, as well as KCl and the α1adrenoceptor agonist, phenylephrine (PE), in order to observe the consequences of putative TRPM8 activation on the tone of vascular rings, from several major arteries and during different contractile states (17) . From these functional experiments, we observed complex effects of TRPM8 agonists on vascular contractility, causing prominent vasodilatations when applied during PE-and high-K + -induced vasoconstrictions, while menthol (300 µM) consistently caused vasoconstrictions when applied to rat tail artery vascular rings at rest. These are disparate effects as menthol-induced activation of TRPM8 would be expected to invariably induce VSM contraction by its virtue of raising [Ca 2+ ]i (43). To add to the puzzle, systemic and chronic dietary administration of menthol is known to have a pronounced hypotensive effect (30, 35) , and in our earlier study we also observed vasodilation of cutaneous blood vessels in vivo after topical menthol application (17) . Such observations strongly imply that there may be other targets for menthol action on blood vessels, apart from TRPM8, for which it is presumed to be a selective agonist that can only be expected to cause Ca 2+ mobilisation and vasoconstriction.
Menthol-induced vasorelaxation has been corroborated in a more recent study that systematically investigated this effect in different rat vascular beds (aortae, mesenteric and coronary arteries) and confirmed its wide-spread existence throughout the vascular system. In this study, Cheang et al. (10) hypothesised that such effect could be explained by the dominant menthol inhibition of VGCC, activation of which normally initiates and maintains VSM contraction during membrane depolarisation, and provided Ca 2+ -imaging and pharmacological evidence for this hypothesis. In this context, it should be noted that (i) smooth muscle and cardiac VGCC are molecularly similar (the principal transmembrane subunit α1 is CaV1.2 type; (9) , and (ii) there is direct patch-clamp evidence for menthol-induced inhibition of cardiac L-type VGCC that occurs at concentrations which normally activate TRPM8 (IC50=75 µM; (6) . However, the hypothesis does not address the entire complexity of menthol action on vascular smooth muscles, as it contradicts measurements of [Ca 2+ ]i rises and vascular contractions of non-stimulated VSM and blood vessels induced by TRPM8 agonists (17, 43) . Moreover, even in pre- 6 constricted vascular rings menthol induces notable initial contraction preceding relaxation (17) . Thus, in the present study, our aims were (i) to identify the effects of TRPM8 agonists (mainly menthol as the most widely used one, and especially interesting as a common ingredient in many medicines and consumer products), on vascular tissues using a range of physiological and biophysical techniques and a much more rigorous set of experiments than previously used aiming to dissect the specific TRPM8-mediated effects, (ii) to further test the hypothesis that TRPM8 is functional in rat tail artery VSM but that the consequences of TRPM8 activation may be masked by non-specific effects of TRPM8 agonists, most likely on VGCC, and (iii) to directly test this latter possibility by patch-clamp measurements of L-type Ca 2+ channel currents.
Some of the results have been communicated in an abstract form (24) . 
Methods
Ethical approval -All experimental procedures involving animals were in accordance with UK Animal Scientific Procedures Act (1986) and were approved by the Queen's University and University of Liverpool Animal Welfare and Ethics Committees.
Animal tissue -Experiments were performed on vessels freshly dissected from 8-to 12-wk-old male Sprague-Dawley rats. Tail arteries were removed from the whole length of the tail. The proximal 2-3 cm of the artery was taken for tensiometric studies, and the rest was used for smooth muscle isolation followed by Ca 2+ measurement or patch clamp analysis.
Vascular smooth muscle isolation -Excised tail arteries were transferred to Ca 2+ -free physiological salt solution (PSS) containing the following (in mM): 120 NaCl, 6 KCl, 1.2 MgCl2, 10 HEPES, and 12 glucose, pH 7.4 (adjusted with NaOH). The artery was cleaned free of connective tissue and longitudinally cut. The endothelium was removed by gently rubbing of the luminal surface with fine stainless steel wire. The tissue was then sectioned into 5-mm lengths before being transferred to dissociation medium (DM) containing the following (in mM): 110 NaCl, 5 KCl, 0.5 KH2PO4, 0.5 NaH2PO4, 10 Na2HCO3, 10 HEPES, 10 taurine, 0.5 EDTA, 10 glucose, 2 MgCl2, and 0.16 CaCl2, pH 7.4 (adjusted with NaOH). The tissue was digested at 37°C for 20 min in DM containing collagenase (type XI; 1 mg/ml), papain (1 mg/ml), BSA (0.4 mg/ml), and dithiothreitol (0.8 mM) and was then washed with Ca 2+ -free PSS to stop digestion. Single myocytes were dispersed by trituration with a small-bore glass pipette.
Electrophysiology -Isolated vascular myocytes were plated in a CoverWell perfusion chamber (Grace Bio-Labs, Sigma-Aldrich Ltd, Dorset, UK) pressed-to-seal to glass coverslips and placed on the stage of an inverting microscope (Nikon Eclipse TE2000-S, Nikon Corp., Tokyo, Japan). 10 minutes prior to commencement of experiments, the cells were superfused with a modified PSS containing (in mM):
NaCl 120, CsCl 6, HEPES 10, MgCl2 1.2, glucose 12, CaCl2 5, pH 7.4 at room temperature.
Borosilicate glass pipettes (Harvard Apparatus Ltd., UK) were fabricated and fire-polished to resistances of 3-4 MΩ and were back-filled with pipette solution 8 containing (in mM): 80 CsCl, 2 MgCl2, 11 EGTA, 7 Na2ATP, 0.5 Na2GTP, 10 HEPES, and 5 creatine (pH 7.3 adjusted with CsOH). Pipette electrodes were mounted on a CV203BU head-stage connected to a patch clamp amplifier (Axopatch 200B, Molecular Devices, Union City, CA, USA). Whole-cell currents were filtered at 2 kHz (8-pole low-pass Bessel) and sampled at 5 kHz.
To determine the presence of a persistent Ca 2+ current (L-ICa) through VGCCs (i.e. the so-called non-inactivating "window current" that occurs in specific range of potentials as an important determinant of vascular tone) in the tail artery VSMCs, a double-pulse voltage protocol was employed with a constant depolarising test potential to 10 mV, preceded by a variable amplitude prepulse ranging from -100 to 40 mV with a 10 mV increment (see upper panel of figure 1A ).
A custom-made solution delivery system consisting of 8 pressurized reservoirs attached to an 8 channel solution delivery pen (AutoMate Scientific, Berkeley, CA, USA) with a single outlet needle (250 μm internal diameter; AutoMate Scientific) was used for fast solution application. The needle outlet was positioned in close proximity (0.1-0.5 mm) to the recorded cell and was used to superfuse the cell with the test compound ("bath solution", "vehicle" or "drug") until a steady-state response had been attained. In addition, a gravity-driven solution exchange attached to one side of the bath and vacuum to the other ensured fast and complete removal of test compounds from the perfusion chamber.
To investigate the direct effects of TRPM8 agonists on calcium currents, L-ICa was activated by applying 400 ms depolarizing pulses to a test potential of 10 mV from a holding potential of -60 mV at 10 s intervals. L-ICa parameters were measured as the peak inward current (L-ICa-Peak) achieved soon after the start of the depolarizing pulse and as the late non-inactivating current (L-ICa-Late) measured as the mean current during the final 10 ms of the 400 ms pulse. To allow quantitative comparison of experimental conditions, all currents were normalised such that L-ICa-Late measured following 30 seconds incubation in nifedipine (10 µM) was set as baseline current for each cell studied. Contraction studies -Tail artery sections with endothelium removed had mechanical responses recorded as previously described (17) . The condition of the tissue was initially tested by adding KCl (60 mM) and rejecting tissue that did not respond with a robust contraction (>0.5 g tension). One of three basic protocols was then conducted. 1) Vessels were examined for a contractile response to menthol alone (0.1-1 mM; experiment performed at room temperature). 2) Vessels were contracted with PE (2 µM) and menthol (300 µM) was added during contraction (having allowed 10 min for contraction to stabilize). 3) To eliminate the involvement of L-type VGCC in TRPM8 agonist-induced responses vessels were incubated with the L-type VGCC antagonist nifedipine (10 µM) for 10 minutes prior to repeating the second protocol.
Ratiometric Ca 2+ recording -Isolated cells in low-Ca
Vascular responses to TRPM8 agonist application were measured as the peak constriction induced (peak response) and the tone remaining 10 minutes after application (late response) relative to PE-induced tone immediately prior, as illustrated in Fig. 4B . Experiments examining the effects of WS-12 (50 µM) were performed and data analysed in the same manner. All summary data presented have been normalized to the PE-vasoconstriction amplitude 10 minutes after PE application.
To determine the specificity of the menthol-induced responses, tail artery vascular rings were preincubated with the TRPM8 antagonist N- Drugs -All drugs were supplied by Sigma-Aldrich (Dorset, UK), except for AMTB (Tocris Bioscience, Abingdon, UK).
Results

ICa in rat tail artery VSMCs and the effects of TRPM8 agonists
To investigate parameters of a persistent L-ICa in tail artery VSMCs, eight cells were recorded using the double-pulse protocol (mean membrane capacitance Cm=42.2±4.0 pF; N=4) and activation (m∞) and inactivation (h∞) curves were constructed from peak amplitudes of L-ICa during the pre-pulse and test steps in a conventional manner ( Fig. 1A,B ). The potentials of half-maximal activation and inactivation (V1/2) were 3.6±1.6 and -18.9±1.1 mV, with the curves having Boltzmann slopes (k) of 15.7±0.6 mV and 9..9±0.7 mV, respectively. Averaged maximal Ca 2+ conductance of 1.34±0.23 nS and very positive reversal potential of the current, 55.5±2.9 mV, suggested adequate L-ICa isolation.
The 'window current', which is maximal at the potential of intersection of these curves, indicates clearly that a persistent ICa is present over a wide range of potentials including within the physiological range of resting potentials in this celltype and those achieved during PE action, with peak at about -10 mV (inset in After examining the activation/inactivation characteristics of the persistent L-ICa, a different protocol was used to investigate the direct effects of TRPM8 agonists on L-ICa. Menthol has been shown previously to inhibit L-ICa in other cell types, namely neurons and cardiac myocytes (6, 36) , suggesting, based on molecular similarities of channels, the presence of such inhibition in vascular myocytes as well.
In the present study, using the same menthol concentration (300 µM) as used in our previous tensiometric experiments (17), we observed strong inhibitory effects of menthol on L-ICa in tail artery VSMCs (Fig. 1C ). Following subsequent nifedipine application for several minutes, a residual transient current was often observed. This current likely represented Ca 2+ influx through T-type VGCCs which are co-expressed with L-type channels in a sub-population of rat tail artery VSMCs (28) . Inactivation kinetics of L-ICa could be well approximated by the sum of two exponentials, and in the presence of menthol it was clearly accelerated (e.g. in Fig 1C τfast was reduced by menthol from 26.6 to 21.0 ms). Thus, menthol is likely to be a gating modifier, rather than a channel blocker that simply hinders the channel pore. However, if a major indirect effect of menthol (e.g. non-TRPM8 related) on vascular tone is vasorelaxation via the inhibition of VGCCs, it is likely that TRPM8 channels present in vessel are also activated but that their role in vascular tone is masked by the more robust action of L-ICa inhibition. Therefore, to minimise this secondary effect ,one method would be to apply menthol to unstimulated VSM, when VGCCs are largely closed at resting potential and L-ICa contribution is minimal (see Indeed, such vasoconstrictions have been observed previously when menthol was applied to pre-tensed rat tail artery sections under resting conditions (17) .
Effect of TRPM8 agonists on VSM [Ca 2+ ]i and basal vascular tone
In rat tail artery VSMCs, menthol induced elevations in [Ca 2+ ]i as well as causing concentration-dependent vasoconstrictions in tail artery vascular rings ( Figs. 2 and 3 ). Enzymatically isolated VSMCs, loaded with fura-2-AM responded to menthol (300 µM) application with robust and reproducible F340/F380 ratio increases, responses that were comparable in size to the responses induced by the application of sub/supra-maximal concentrations of the ryanodine receptor (RyR) channel activator caffeine (1-10 mM) and α1-adrenoceptor agonist PE (2-10 µM) when tested in the same cell ( Fig. 2A, B) . The summary bar chart shows the peak increases in However, there was one notable difference in the rate of rise of these various Ca 2+ signals (quantified as time from 10 to 90% of its maximal size, or t10-90), as menthol-induced responses were significantly slower compared to caffeine-or PEinduced responses (Fig. 1D, E) . This observation suggests that the density of TRPMmediated Ca 2+ influx into the cytosol should be considerably lower compared to the pathways that involve α1-adrenoceptor and ryanodine receptor activation.Consistent with these findings at the cellular level, application of incremental concentrations of menthol to pre-tensed, non-constricted tail artery vascular rings at room temperature (20-22 O C) induced vasoconstrictions that were concentration-dependent (100 µM: 0.020±0.003 g or 4±1% of KCl vasoconstriction; n=29, N=14; 300 µM: 0.062±0.010 g or 10±1 % of KCl; n=29, N=14; NS ; 500 μM: 0.115±0.013 g or 17±2 % of KCl; n=29, N=14; 1 mM: 0.339±0.032 g or 52±5 % of KCl; n=29, N=14) and were significantly greater than baseline (300 µM -P<0.01; 500 µM -P<0.001; 1 mM -P<0.001; peak amplitudes significantly different from zero, one-way ANOVA; Fig. 3 ). When menthol (300 μM) was applied to pre-tensed, relaxed tail artery vascular rings at 37°C vasoconstrictions were significantly smaller (0.025±0.004 g or 3±1 % of KCl; n=8, N=3; P<0.01; unpaired t-test with Welch's correction) than those observed at room temperature and were more transient in appearance (see Fig. 3A , inset). These results are consistent with synergy between cold and menthol in TRPM8 activation, e.g. menthol was shown to activate TRPM8 much more efficiently at 22 O C compared to 35 O C (27) . Clearly, menthol mediates Ca 2+ -mobilising effects sufficient to trigger significant vasoconstrictions. These findings indicate that the most likely mechanism of menthol-induced vasodilatation of pre-constricted vessels ((17) and Fig. 4A, left panel) was a direct effect on VSM VGCCs, since this effect was reversed in the absence of L-type VGCC contribution to PE-vasoconstrictions ( Fig. 4A, right panel) . Importantly, these experiments indicate that the inhibition by menthol of L-ICa, which is more pronounced for its late component (Fig. 1E) , also likely masks a substantial part of the vasoconstrictive effects of the compound even in non-stimulated tissue since even at the resting membrane potential considerable "window" Ca 2+ current (up to 40% of maximum) flows (inset, Fig. 1B ) contributing to resting vascular tone.
Effect of TRPM8 agonists on vascular tone independent of VGCC activity
Ca 2+ store contribution to menthol-induced vasoconstrictions
In different cell types, TRPM8 channels can be expressed not only in the plasma membrane, where they mediate Ca 2+ influx, but also in the endoplasmic reticulum, where they promote Ca 2+ release from the intracellular stores (1, 7, 8, 32, 36, 43) . In this context, it should be noted that menthol is a membrane permeable molecule. In addition, it is possible that TRPM8-mediated Ca 2+ influx can trigger Ca 2+ -induced Ca 2+ release. To determine whether intracellular Ca 2+ stores contributed to menthol-induced vasoconstrictions, we inhibited re-uptake of Ca 2+ into the sarcoplasmic reticulum (SR) using the sarco/endoplasmic reticulum calcium ATPase pump inhibitor cyclopiazonic acid (CPA). When vessels were pre-incubated with CPA (10 µM) for 30 minutes prior to a PE-induced vasoconstriction, application of menthol (300 µM) 10 minutes later did not induce any increase in tone (peak) as was seen in control conditions, but instead, resulted in a more pronounced vasodilatation that was significantly greater than seen in the absence of CPA Fig. 5A,B) .
To strengthen the theory that menthol activation of TRPM8 could result in Ca 2+ release in tail artery VSMCs to contribute to vasoconstriction, immunocytochemistry was performed on isolated tail artery myocytes using a specific TRPM8 antibody. A thin, intense immunofluorescence signal on the perimeter of the cell was identified, as well as a pronounced signal within the deeper cytosol ( Fig 5C, left panel) . These signals could be attributed to TRPM8 presence at plasmalemma and/or sub-plasmalemmal SR in addition to a large intracellular structure surrounding the nucleus, most likely the SR. This hypothesis was confirmed by the parallel labelling of type I InsP3 receptors (Fig. 5C, middle panel) followed by examination of merged images, which revealed such colocalisation of TRPM8 and InsP3R, as evident by yellow color in Fig. 5C , right panel. These results are consistent with the view that TRPM8 can be localised both on the plasma membrane and/or the SR membrane, and mediates Ca 2+ influx and/or Ca 2+ release correspondingly, as in other cell types (1, 7, 8, 32, 35, 37, 44) .
This enhanced vasorelaxation after CPA treatment could, at least in part, be attributed a relatively larger contribution of VGCC activity to PE-induced vasoconstrictions when SR was dysfunctional. To distinguish between these possibilities we next focused on the role of SR in menthol-evoked Ca 2+ responses. In order to evaluate the relative contribution of VGCC-mediated Ca 2+ influx vs Ca 2+ store release to menthol-evoked intracellular Ca 2+ rise, ratiometric Fura-2 measurements were performed on single myocytes, while VGCC were inhibited by nicardipine (5 μM) or Ca 2+ store was depleted with CPA (10 µM), respectively. While nicardipine had no statistically significant effect, the Ca 2+ transients in response to menthol were inhibited by 48.9±1.2% (n=3) after Ca 2+ store depletion (Fig. 6 ). It should be noted, that this effect of Ca 2+ store depletion on the amplitude of menthol-induced Ca 2+ response is even underestimated since the measured F340/F380 signal includes, in addition to the menthol-induced signal, also a more sustained storeoperated Ca 2+ entry component, as can be seen in panel Fig. 6C .
Consistent with this, in confocal Ca 2+ imaging experiments performed on single Fluo-3 AM loaded myocytes with the use of the MR-A1 system we observed significant intracellular Ca 2+ rises both with and without external Ca 2+ , with indications of a propagating through the cytosol Ca 2+ wave -phenomenon typically attributed to Ca 2+ -induced Ca 2+ release process ( Fig. 7A-C Fig. 7A and B) . This strongly indicates that menthol, by presumably acting on TRPM8 channels expressed on the SE membrane ( Fig. 5C ), reduces the Ca 2+ content that be liberated by caffeine.
To investigate the spatial dynamics of menthol-induced [Ca 2+ ]i rises at a higher temporal resolution, we employed the spinning Nipkow disc system. With the improved temporal resolution we observed that, indeed, menthol clearly induced a propagating through the cytosol Ca 2+ wave in the presence (Fig. 7D, top 
Effect of TRPM8 antagonist (AMTB) on menthol-induced vasoconstrictions in the presence of nifedipine
We next examined the selectivity of menthol action with regard to TRPM8 activation, expecting loss of its effect following TRPM8 blockade by AMTB. In the presence of AMTB (10 µM), menthol-induced vasoconstrictions in the absence of VGCC contribution (Fig. 8A, left % of the PE control, respectively (peak: P<0.01; late: P<0.001; one-way ANOVA; n=9, N=9) when preparations were pre-incubated in nifedipine plus AMTB (Fig. 8B) .
Effects of other TRPM8 agonists on ICa in rat tail artery VSMCs
In addition to menthol, we examined the effects of two other, more recently introduced TRPM8 agonists (icilin and WS-12) on L-ICa in tail artery VSMCs (Fig. 9) .
The concentration of icilin tested was the same as used in our previous tensiometric experiments (17) and as deemed sufficient for supramaximal activation of TRPM8 (50 µM). WS-12 was used at its supramaximal concentration of 50 µM (33) . As shown in Fig. 9A , both agonists had strong inhibitory effects on L-ICa in these cells.
Similarly to menthol, iclin accelerate current inactivation of L-ICa (e.g. in Fig 9A τfast was reduced by icilin from 32.4 to 25.5 ms). Thus, icilin is also likely to be a VGCC gating modifier. 
These observations in vascular cells contrast to those in rabbit cardiac myocytes
where icilin appeared to have no effect on L-ICa (6) .
The latter observation that WS-12 had little or no effect on the sustained L-ICa suggested that this menthol derivative is a more selective TRPM8 agonist compared to menthol. We have thus performed similar to the above described Ca 2+ ratiometric measurements using Fura-2 AM loaded myocytes ( Fig. 10 ) and contractile recordings ( Fig. 10B , data summarised in Fig. 10C ). WS-12 (10 μM) induced robust [Ca 2+ ]i rises comparable to those induced by caffeine, PE or menthol (Fig. 10A ).
However, similar to menthol, the rise phase of these responses was much slower compared to caffeine-and PE-induced responses, with t10-90=6.16±1.97 s (n=4) (compare to Fig. 2E ). When applied in the presence of PE WS-12 invariably induced an additional contraction, which was augmented in the presence of nifedipine (Fig.   10B, C) . This indicates, that although some L-ICa occurred (i.e. vehicle only effect in case of late L-ICa), the associated relaxation component was masked by a more pronounced contractile component due to TRPM8 activation. 20 
Discussion
The present study confirms that vasodilatory effects of menthol on preconstricted vascular rings (10, 17) are mediated via a direct inhibitory action on Ltype VGCCs. We thus refer to this effect as nonspecific if menthol is employed as pharmacological tool for the investigation of physiological effects of TRPM8 activation. When organ bath tensiometric experiments were performed on tail artery rings in the presence of nifedipine, TRPM8 agonist-induced vasodilatations were abolished indicating that these were a consequence of a direct inhibition of L-type VGCC activity. However, it should be noted that moderate contribution of endothelium to these relaxations was observed (17) , and this likely holds true considering VGCC are lacking in endothelial cells, although further tests of endothelium involvement are now needed using experimental protocols we developed here for testing TRPM8 specific roles. However, in the present study the endothelium was removed to avoid this additional complexity.
It is now well documented that menthol interacts with proteins other than TRPM8. It has been shown that the compound can potently inhibit skeletal muscle and neuronal voltage-operated Na + channels (15) , neuronal and cardiac VGCCs (6, 36 ) and now smooth muscle VSMCs ((10) and present study). These findings could be expected considering the similarity of vascular to cardiac muscle VGCC molecular composition (9) . In addition, menthol has also been shown to activate TRPV3 at mM concentrations and bi-modally activate and inhibit TRPA1 in a concentration-dependent manner (18, 21) . Millimolar concentrations have also been shown to induce Ca 2+ release from the internal stores in non-TRPM8-expressing HEK293 cells (22) . Thus, in the present study a combination of a number of different TRPM8 agonists and selective TRPM8 antagonist AMTB were used to determine whether a specific and physiologically relevant TRPM8-mediated effect existed in tail artery VSMCs.
In spite of its robust inhibitory effects on L-ICa, we show that menthol induces robust Ca 2+ -mobilising effects in tail artery VSMCs that were comparable with caffeine and PE. In addition, at room temperature, menthol induced concentrationdependent vasoconstrictions in the organ bath preparation. Cheang et al. (10) noted that they did not observe vasoconstrictive effects of menthol in rat aorta, mesenteric artery or coronary artery at 37°C. This is in agreement with our own observations (unpublished). Menthol vasoconstrictions were only investigated in tail artery
Commented [A1]: Moved below
vascular rings in the present study, and moreover, were larger and observed more consistently at room temperature. Clearly, the very complex interactions between voltage, menthol and temperature in TRPM8 activation (2, 14, 40) may explain these differences depending on temperature at which experiments are performed, as there is strong synergy between cooling and menthol (2, 15, 43) . Indeed, according to L-type Ca 2+ currents described in previous studies (10, 17) . In addition, menthol application to the organ bath while vascular rings were at basal tone also produced significant vasoconstrictions, though these were usually only observed when experiments were performed at room temperature. The observation that mentholinduced vasoconstrictions became more pronounced at 37 o C in the presence of PE (compare Fig. 8A and Fig. 3A ) could be explained by several factors. First, we found significant colocalisation between TRPM8 and InsP3R1 (Fig. 5C ). Since InsP3R activity is potentiated by [Ca 2+ ]i rise it is possible that Ca 2+ efflux via TRPM8 in its close vicinity potentiates PE-induced Ca2 + signalling via InsP3R. Second, TRPM8 has been recently shown to activate Gq proteins directly, and thus it can synergise with α1-adrenoceptor in this same action (20) . Third, although Ca 2+ influx via TRPM8 makes prominent contribution to the menthol-induced Ca 2+ responses (Fig.   7A,B ,E), one should not overlook the importance of Na + influx, as TRPM8 is a nonselective cation channel primarily admitting Na + under physiological gradients.
Indeed, Na + entry via the Na + -Ca 2+ exchanger (NCX) facilitates Ca 2+ entry via the NCX operating in the reverse mode, and this way it contributes to PE-induced [Ca 2+ ]i oscillations and vasoconstriction. This mechanism becomes even more important in the presence of nifedipine (21) , which is consistent with our observations assuming that TRPM-mediated Na + entry facilitates Ca 2+ entry via the reverse-mode of NCX.Mahieu et al. present study were indeed a non-specific effect of the compound, it is reasonable to suggest that they would induce similar non-specific effects in other vascular beds.
Menthol was applied to organ bath preparations of rat aorta, mesenteric artery and femoral artery vascular rings at both room temperature and 37°C, but had no effect on basal tone (data not shown).
We found that menthol-induced vasoconstrictions in the presence of PE were mediated, at least in part, by Ca 2+ -release from the internal stores, since they were abolished by CPA pre-treatment which is known to deplete the Ca 2+ store. Moreover, in the absence of the vasoconstrictive component of menthol's action after Ca 2+ store depletion, the vasodilatory effect of the compound was significantly greater.
The involvement of TRPM8 in Ca 2+ release is further supported by the localization of anti-TRPM8 immunofluorescence signals in close proximity to type I InsP3 receptors on intracellular structures analogous to SR (41) in immunocytochemistry experiments performed on isolated rat tail artery VSMCs. In mouse mesenteric artery myocytes, TRPM8 is also mainly localised in the cytosolic region (35) . In menthol induced [Ca 2+ ]i transients, the large initial transient component was also suggestive of predominant Ca 2+ release contribution.
Furthermore, a significant population of these intracellular TRPM8 channels showed colocalisation with type I InsP3 receptors, although it is possible that another part of intracellular TRPM8 staining simply represents synthesis and transport of TRPM8 proteins. Despite this uncertainty, in our Ca 2+ confocal imaging experiments we obtained strong evidence for the contribution of both Ca 2+ influx and Ca 2+ release (the latter was evident after external Ca 2+ removal) to [Ca 2+ ]i rises induced by menthol, and we also found that menthol partially reduces the caffeine-releasable Ca 2+ pool. In addition, ratiometric Ca 2+ measurements showed significant reduction of menthol-induced Ca 2+ transients following Ca 2+ store depletion by CPA treatment.
Taking together, these observations provide strong structural and functional evidence for the role of TRPM8 channels expressed in the SR. Notably, however, menthol (and WS-12) [Ca 2+ ]i rises developed much more slowly compared to those initiated by PE (mainly via activation of InsP3 receptors) and caffeine (via activation of RyR receptors). This difference can in part be explained by slower diffusion of TRPM8 agonists into the cytosol, but it is more likely that lower expression of TRPM8 channels and/or the lack of their positive feedback activation by Ca 2+ , as is the case for both InsP3 and RyR receptors, can account for such differences in kinetics.
Furthermore, menthol-induced vasoconstrictions were significantly reduced in the presence of the selective TRPM8 antagonist AMTB, as an additional independent test of specificity. Notably, the physiologically-relevant involvement of TRPM8 in Ca 2+ release mediated by the intracellular (ER) TRPM8 channels has also been documented in other cells types, such as DRG neurons, normal prostate secretory epithelial cells, and in LNCaP cells, a prostate cancer cell-line (7, 8, 37, 39, 44) .
While menthol has previously been shown to inhibit VGCCs, the present study is the first that we know of that describes inhibitory effects of icilin and WS-12 on L- sequence variations, there is further possibility for variation of responses to pharmacological reagents due to tissue-specific alternative splicing resulting in altered channel structures (11, 19) . Among the three TRPM8 agonists, WS-12 appears to be the most selective one, at least it did not affect late component of L-ICa (although this was still inhibited to some extent by vehicle). Correspondingly, the vasorelaxation phase was absent when WS-12 was applied in the presence of PE.
In conclusion, the TRPM8 agonist menthol has dual effects on vascular tone, normally resulting in a biphasic response (trace 1 in Fig. 11A ). Menthol causes an endothelium-independent non-specific vasodilatory effect as a result of L-ICa inhibition, which could be "unmasked" by interrupting normal Ca 2+ release (trace 2 in Fig. 11A) , and a TRPM8-mediated vasoconstriction effect that was at least partly dependent on normal Ca 2+ release, which could be "unmasked" under conditions in which VGCC activity was minimised (trace 3 in Fig. 11A ). We thus propose that TRPM8 is expressed and functional in rat tail artery VSM and that it is potentially localised both on the plasma membrane and the sarcoplasmic reticulum, the latter 
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Figure legends
Figure 10
The more selective TRPM agonist, menthol-derivative WS12, induces [Ca 2+ ]i rises in single Fura-2 AM loaded rat tail artery myocytes and, in tensiometric recordings, 37 alters the balance between vasoconstriction and vasorelaxation towards predominant contraction.
A -Ratiometric [Ca 2+ ]i recording of a representative Fura-2-loaded VSMC that responded to caffeine (10 mM), PE (10 μM), WS-12 (10 μM) and menthol (300 μM) with increases in F340/F380 ratio. B -WS-12 induces vasoconstrictions in rat tail artery vascular rings both with and without VGCC activity. Representative tensiometric trace showing that WS-12 (50 μM) had a predominantly vasoconstrictive effect (i.e. no net vasorelaxation phase was evident) on PE-constricted rat tail artery vascular rings that was potentiated in the presence of nifedipine (n=12, N=7).
C -The bar chart on the left shows summary data quantifying the effects of WS-12 when applied 10 minutes into a PE-vasoconstriction, causing a significant vasoconstriction (Peak) followed by a prolonged elevated tone measured 10 minutes after WS-12 application (Late, compared to menthol no relaxation was evident). The bar chart on the right shows summary data of similar measurements performed during incubation with nifedipine applied 10 minutes prior to the application of PE.
Both Peak and Late responses were increased, suggesting that some "unmasking" of the contractile response in the absence of VGCC activity still takes place.
Figure 11
Normalised superimposed tensiometric traces demonstrating the effects of menthol on vascular tone under different experimental conditions and a schematic model of the probable underlying mechanisms.
A -Demonstrative tensiometric traces showing representative effects of menthol in control conditions (1) , and in the absence of either VGCC (2) or SR Ca 2+ (3) involvement, as indicated. Responses have been normalised to the tension observed 10 minutes after PE (2 µM) application in each experimental condition. In other words, traces were scaled such that at the moment of menthol application all three had the same amplitude, i.e. the level of tension after 10 minutes, just prior to the application of menthol represents 100% PE-induced contraction.
B -Schematic mechanistic model showing the potential pathways by which the TRPM8 agonist menthol induces its multiple effects on vascular tone through the activation of the intracellular (major) and plasma membrane TRPM8 channels to cause vasoconstriction and through the inhibition of VGCC to cause vasorelaxation.
